A
Aardvark Therapeutics Inc
NASDAQ:AARD
Aardvark Therapeutics Inc
NASDAQ:AARD
Price:
5.09
USD
-3.23%
Market Closed
Market Cap:
$110.8m
Income Statement
Earnings Waterfall
Aardvark Therapeutics Inc
Aardvark Therapeutics Inc
Income Statement
Aardvark Therapeutics Inc
Aardvark Therapeutics Inc
Currency: USD
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||
| Operating Expenses |
(23)
|
(33)
|
(41)
|
(53)
|
|
| Selling, General & Administrative |
(5)
|
(8)
|
(8)
|
(11)
|
|
| Research & Development |
(17)
|
(25)
|
(33)
|
(43)
|
|
| Operating Income |
(23)
N/A
|
(33)
-46%
|
(41)
-23%
|
(53)
-31%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
2
|
3
|
4
|
5
|
|
| Pre-Tax Income |
(21)
N/A
|
(30)
-45%
|
(37)
-23%
|
(49)
-33%
|
|
| Net Income | |||||
| Income from Continuing Operations |
(21)
|
(30)
|
(37)
|
(49)
|
|
| Net Income (Common) |
(21)
N/A
|
(30)
-45%
|
(37)
-23%
|
(49)
-33%
|
|
| EPS (Diluted) |
-0.96
N/A
|
-2.26
-135%
|
-1.68
+26%
|
-2.24
-33%
|
|
Switch to:
Switch to:
See Also
Discover More
